Help us: Donate
Follow us on:

Dorian Therapeutics

Organization Description


Dorian Therapeutics is a company developing senoblockers, a new class of therapeutics that can rejuvenate cells and tissues. Based on a patented technology developed at Stanford University, Dorian’s team is bringing to the clinic an innovative solution for age-associated diseases.


Maddalena Adorno, Ph.D.

Dorian Therapeutics - CEO